NJ State Employees Deferred Compensation Plan - CYTOKINETICS INC ownership

CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 256 filers reported holding CYTOKINETICS INC in Q3 2023. The put-call ratio across all filers is 2.72 and the average weighting 0.2%.

Quarter-by-quarter ownership
NJ State Employees Deferred Compensation Plan ownership history of CYTOKINETICS INC
ValueSharesWeighting
Q3 2023$456,630
-9.7%
15,5000.0%0.07%
-5.5%
Q2 2023$505,610
-7.3%
15,5000.0%0.07%
-13.1%
Q1 2023$545,445
+58.7%
15,500
+106.7%
0.08%
+50.0%
Q4 2022$343,650
-5.3%
7,5000.0%0.06%
-9.7%
Q3 2022$363,0007,5000.06%
Other shareholders
CYTOKINETICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 223,382$6,580,8347.72%
Finepoint Capital LP 431,693$12,717,6766.33%
Saturn V Capital Management LP 495,168$14,587,6496.11%
Logos Global Management LP 1,250,000$36,825,0004.91%
DAFNA Capital Management LLC 479,538$14,127,1894.39%
PFM Health Sciences, LP 2,399,545$70,690,5963.33%
Boxer Capital, LLC 2,100,000$61,866,0003.29%
Integral Health Asset Management, LLC 800,000$23,568,0003.26%
GREAT POINT PARTNERS LLC 600,000$17,676,0003.22%
Nicholas Investment Partners, LP 942,137$27,755,3562.07%
View complete list of CYTOKINETICS INC shareholders